BioSpace News Archive

OTCQX Best Market to provide Aleafia with increased exposure and accessibility to the expanding U.S. and global shareholder base [13-June-2018] NEW YORK, June 13, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Aleafia Health Inc. (TSX-V: ALEF; OTCQX: ALEAF), a

PellePharm today announced that the company is scheduled to participate in the Cantor Fitzgerald Dermatology and Aesthetics Summit.

Flex Pharma, Inc. today announced that the Company is ending its ongoing Phase 2 clinical trial investigations of FLX-787 in amyotrophic lateral sclerosis (ALS) and Charcot-Marie-Tooth (CMT).

The 21st edition of The Sanofi Canada Healthcare Survey of Canadian employees with workplace health benefit plans (plan members) and of organizations who offer their employees health benefits (plan sponsors) indicates that while 58% of surveyed plan members report having at least one chronic disease or condition, plan sponsors underestimate the proportion of their workforce with a chronic condition (29%).

Award recognizes entrepreneurs who are excelling in areas such as innovation, financial performance, and personal commitment to their businesses and communities

Approximately 10 Percent of Patients With Genetic Changes Associated with Disease Show Copy Number Variant Changes That May Go Undetected by Traditional Approaches

Synergy Pharmaceuticals Inc. today announced that it has received a waiver to extend the draw down date of the second borrowing under its Term Loan Agreement with CRG LP.

Financing Will Enable Stride to Move Multiple Programs Towards the Clinic

Stanson’s Clinical Decision Support Technology will be Deployed System-wide

SQI Diagnostics Inc. is pleased to announce the appointment of global healthcare executive Eric Zwisler, to its Board of Directors.